In two recent letters to dietary supplement companies, the FDA has reiterated its position that a product containing cannabidiol (CBD) cannot be marketed as a dietary supplement. A July 23 letter to Tim Orr, senior vice president of Charlotte’s Web Inc., came in response to a new dietary ingredient (NDI) submission that the company sent to the FDA for the product Charlotte’s ... Read More